You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., June 8, 2018 /PRNewswire/ -- Astellas today appointed Nahrin Marino to vice president, head of Ethics & Compliance, Americas effective July 15. Previously, Marino served as deputy general counsel, Regulatory for Astellas. She will direct a team of professionals in Canada, United States and Latin America, and will report to Senior Vice President and Head of Ethics & Compliance Tatjana Dragovic who has responsibility for the global function.
"Nahrin acts with the highest sense of ethics and integrity, which will enable our team to advance our mission of maintaining Astellas' commitment to the highest ethical standards," said Dragovic. "Nahrin is not only an accomplished attorney who has worked closely with Ethics & Compliance over the years, but also is a role model for Astellas serving actively as a professional mentor and community volunteer."
Marino began her career in the pharmaceutical industry as a professional healthcare representative in 1999. Prior to Astellas, she worked at Dykema Gossett, representing corporations in pharmaceutical and medical device litigation. She joined Astellas in 2010 as senior corporate counsel, rising to her current position following several promotions and increasing responsibilities within the company. Marino is an active member of Astellas' Stellar Women Employee Resource Group, whose mission is to create an environment of empowerment and advocacy to advance and inspire women at Astellas. In May 2018, she received the Luminary Award from the Healthcare Businesswomen's Association (HBA). Marino received her undergraduate degree in biology from the Illinois State University and graduated magna cum laude from The John Marshall Law School.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
SOURCE Astellas Pharma US, Inc.
![]() |
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.